HLB Pharmaceutical Co., Ltd. 047920.KQ Stock
HLB Pharmaceutical Co., Ltd. Price Chart
HLB Pharmaceutical Co., Ltd. 047920.KQ Financial and Trading Overview
| HLB Pharmaceutical Co., Ltd. stock price | 19500 KRW |
| Previous Close | 14240 KRW |
| Open | 14240 KRW |
| Bid | 14370 KRW x 0 |
| Ask | 14380 KRW x 0 |
| Day's Range | 14210 - 14680 KRW |
| 52 Week Range | 10000 - 27500 KRW |
| Volume | 124.3K KRW |
| Avg. Volume | 559.7K KRW |
| Market Cap | 199.27B KRW |
| Beta (5Y Monthly) | 1.831235 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 KRW |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
047920.KQ Valuation Measures
| Enterprise Value | 175.43B KRW |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5.519952 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 4.859 |
| Enterprise Value/EBITDA | 56.945 |
Trading Information
HLB Pharmaceutical Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 1.831235 |
| 52-Week Change | 9.96% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 27500 KRW |
| 52 Week Low | 10000 KRW |
| 50-Day Moving Average | 14908.8 KRW |
| 200-Day Moving Average | 14129.5 KRW |
047920.KQ Share Statistics
| Avg. Volume (3 month) | 559.7K KRW |
| Avg. Daily Volume (10-Days) | 243.75K KRW |
| Shares Outstanding | 13.85M |
| Float | 7.04M |
| Short Ratio | N/A |
| % Held by Insiders | 17.41% |
| % Held by Institutions | 0.45% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 1.5:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2019 |
| Most Recent Quarter (mrq) | December 31, 2019 |
| Next Fiscal Year End | December 31, 2020 |
Profitability
| Profit Margin | 1.30% |
| Operating Margin (ttm) | 3.99% |
| Gross Margin | 49.97% |
| EBITDA Margin | 8.53% |
Management Effectiveness
| Return on Assets (ttm) | 2.18% |
| Return on Equity (ttm) | 2.70% |
Income Statement
| Revenue (ttm) | 36.1B KRW |
| Revenue Per Share (ttm) | 2606.8 KRW |
| Quarterly Revenue Growth (yoy) | 49.60% |
| Gross Profit (ttm) | 18.04B KRW |
| EBITDA | 3.08B KRW |
| Net Income Avi to Common (ttm) | 472.66M KRW |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 15.16B KRW |
| Total Cash Per Share (mrq) | 1094.97 KRW |
| Total Debt (mrq) | 13.2B KRW |
| Total Debt/Equity (mrq) | 73.72 KRW |
| Current Ratio (mrq) | 1.257 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | 1.35B KRW |
| Levered Free Cash Flow (ttm) | 1.81B KRW |
Profile of HLB Pharmaceutical Co., Ltd.
| Country | South Korea |
| State | N/A |
| City | Namyangju-Si |
| Address | 778-1 Ilpaedong |
| ZIP | N/A |
| Phone | 82 411 1500 |
| Website | https://www.c-tri.co.kr |
| Industry | |
| Sector(s) | |
| Full Time Employees | N/A |
HLB Pharmaceutical Co., Ltd, a pharmaceutical company, develops peptide drugs in South Korea. The company offers skeletal muscle relaxants, tranquilizers, antihistamines, antihypertensive agents, pain relief, antipruritics, astringents, anti-inflammatories, alimentary system drugs, metabolic drugs, ophthalmic agents, local anesthetics, antiarteriosclerotic agents, expectorants, antipyretics, analgesics, antidiabetic drug, chemotherapeutics, peptic ulcer agents, central nervous system drug, antibiotics, digestives, antacids, dental drugs, multivitamins, parasistic skin disese drugs, dermatlogicals, agents for urogenital organ, amino acid agent, antitussive, mucolytic agents, anthelmintics, antidiarrheals, circulatory system drug, vitamins, skin softeners, anti-hemorrhoid drugs, and agents for liver disease. It is also developing CTT-004 for the treatment of ataxia induced by spinocerebellar degeneration; and offers CMO services. The company was formerly known as Mediforum Pharmaceutical Incorporation and changed its name to HLB Pharmaceutical Co., Ltd in October 2020. HLB Pharmaceutical Co., Ltd was founded in 1998 and is headquartered in Namyangju, South Korea.
Q&A For HLB Pharmaceutical Co., Ltd. Stock
What is a current 047920.KQ stock price?
HLB Pharmaceutical Co., Ltd. 047920.KQ stock price today per share is 19500 KRW.
How to purchase HLB Pharmaceutical Co., Ltd. stock?
You can buy 047920.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for HLB Pharmaceutical Co., Ltd.?
The stock symbol or ticker of HLB Pharmaceutical Co., Ltd. is 047920.KQ.
How many shares does HLB Pharmaceutical Co., Ltd. have in circulation?
The max supply of HLB Pharmaceutical Co., Ltd. shares is 31.75M.
What is HLB Pharmaceutical Co., Ltd. Price to Earnings Ratio (PE Ratio)?
HLB Pharmaceutical Co., Ltd. PE Ratio is now.
What was HLB Pharmaceutical Co., Ltd. earnings per share over the trailing 12 months (TTM)?
HLB Pharmaceutical Co., Ltd. EPS is 0 KRW over the trailing 12 months.